Defining a Cancer Dependency Map

Tsherniak, Aviad, Vazquez, Francisca, Montgomery, Phil G., Weir, Barbara A., Kryukov, Gregory, Cowley, Glenn S., Gill, Stanley, Harrington, William F. +17 more·2017·Cell
DOI 10.1016/j.cell.2017.06.010

Cited by (1,075)

Items 801–900 of 1,075

  1. Explainable/interpretable artificial intelligence and knowledge graph neural network for synthetic lethality prediction: overview, challenges, and future directions
    Salsabil Felloussi, Fatima El Haoussi, Hamid Tairi, Noura Aherrahrou · 2026 · Briefings in Bioinformatics
  2. Confounders of lncRNA screens: sources, consequences and possible solutions.
    Juan J. Montero, Riccardo Trozzo, Roland Rad · 2026 · Nature Methods
  3. Steric Gating Contributes to the Preferential Ubiquitin Charging of BIRC6 by UBA6 versus UBA1
    Ze-Bin Tong, Ru-Jing Yuan, Xiang-Wei Wu, Hong-Yi Cai, Zi-Yu Xu, Lei Liu, Hua-Song Ai · 2026 · Nature Communications
  4. Data-centric feedback loops for next-generation immunotherapy development
    Rotem Shalita, Ido Amit · 2026 · Nature Biomedical Engineering
  5. DepPrior: integrating CRISPR dependency predictability with multi-omics reproducibility to prioritize candidate LUAD therapeutic targets
    Feng-Fei Zhou, Cheng Wang, Li-Zhi Mo, Xuan Sun, Ji Zhang · 2026 · Frontiers in Pharmacology
  6. XMAn Update - A Database of Homo sapiens Mutated Peptides
    Joshua R. S. Haueis, I. Lazar · 2026 · bioRxiv
  7. Orchestra: Corroboration-Based Regulatory Candidate Discovery via Composed Bioinformatics MCP Agents
    Jose A. Bird · 2026
  8. SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications
    Marcela Briones-Martín-del-Campo, Alex Gia Lee, Truc Dinh, Virginie Marchand, Yuri Motorin, Marta Román, Qiuli Bi, Stanley G. Leung, Max A. Horlbeck, Leanne C. Sayles et al. · 2026 · NAR Cancer
  9. Assay concordance sets exact ceilings on what one biological score can predict
    Zongming Liu · 2026 · bioRxiv
  10. Tumor control of lysosomal acidification promotes lipoprotein assimilation and ferroptosis resistance
    Renfei Wu, Sheng-Chieh Hsu, Lingjie Sang, Miao-Miao Yu, Y. Kim, M. Choe, C. Hauer, Ling Cai, A. Hanker, Isaac S. Chan et al. · 2026 · bioRxiv
  11. The Dual Face of Gingival Mesenchymal Stem Cell Paracrine Signalling in Oral Squamous Cell Carcinoma: A Pro-Tumour Transcriptional Programme and a Hypothesis-Generating Drug-Repurposing Screen
    Abdullah Alqarni, J. Hosmani, S. Arem, H. Almubarak, H. Assiri, R. Meer, Shankargouda Patil · 2026 · Cells
  12. Evaluation of HDAC8 as a Druggable Target in STAG2 -Mutant Ewing Sarcoma
    Olasunkanmi O. Olaoye, Yuan Xiong, Cory D. Rillahan, Biniam Adane, Giulia DiGiovanni, Kenneth N. Ross, Gabriela Alexe, Briana Howard, Nadia Kirmani, Radosław P. Nowak et al. · 2026 · ACS Chemical Biology
  13. PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.
    Zhendong Cao, Kurtis N. McCannell, Si-Xiang Yu, Krista A. Budinich, Won Jun Kim, Yu-Qing Jing, Michelle Wang, Steven Tittley, Z. Wen, K. Liu et al. · 2026 · Leukemia
  14. Predicting gene compensation in disease with graph embedding techniques
    Federico García-Criado, J. Pérez-García, E. Rojano, Pedro Seoane-Zonjic, J. A. Ranea · 2026 · Artif. Intell. Medicine
  15. PerturbTrace: Evaluating Feedback Use by AI Co-Scientist Agents in Perturbation Discovery
    Chang-Jie Yu, Si-Yu Liu, Guan-Ren Qiao, Ming-Rui Luo, Yu-Jia Xiang, Zhi-Ping Xu · 2026 · bioRxiv
  16. Transcriptome-based macroautophagy and chaperone-mediated autophagy states reveal context-dependent vulnerabilities across human cancers.
    Ji-Ling Feng, Yu Zeng, Hao Wu, Yuan-Long Feng, Sheng-Nan Luo, Shuxian Dong, Sheng-Li Li · 2026 · Autophagy
  17. Defective microhomology-mediated end joining in SMARCB1-deficient tumors
    Guang-Li Zhu, S. Asada, Huy Nguyen, Y. Hirohashi, Li-Fang Sun, Avneesh Saravanapavan, Erfan Rahmani, Maryia Hrynashka, S. Mukkavalli, Mona Batish et al. · 2026 · Science Advances
  18. Lineage master regulator and cancer-selective partner transcription factors rewire 3D genome topology for tumor-specific gene control
    N. Jung, V. Lopez-Pajares, L. Donohue, M. Guo, Suhas Srinivasan, Z. Siprashvili, P. Khavari · 2026 · Science Advances
  19. Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD)
    Shabnam Pirestani, Émmanuelle Nicolas, Robert L. Broadrup, Margie L. Clapper, Erica A. Golemis · 2026 · Cancer and Metastasis Reviews
  20. A high-throughput co-culture CRISPR array for rapid fitness hypothesis testing and growth engineering in CHO cells
    Jannis Marzluf, Lea Huckfeldt, Dominik Haidas, Christoph Zehe, Ann‐Cathrin Leroux · 2026 · iScience
  21. Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling
    Vincent Lavelle, Yi-Tan Zhu, Kaitlyn Marlor, Thomas S. Brettin, Rick L. Stevens · 2026 · arXiv.org
  22. EIF2S1-PELO co-expression architecture in human brain: pairing-family decomposition reveals constitutive transcriptional coupling and functional layer separation
    Drake H. Harbert · 2026 · Frontiers in Molecular Neuroscience
  23. Mitotic adaptations shape acquired resistance and vulnerabilities to KIF18A inhibition in cancer
    S. Klaasen, Kruno Vukušić, Michael R. van Gerven, H. van Attikum, I. Tolić, M. S. Luijsterburg · 2026 · bioRxiv
  24. VCAgent: A Mutation-Guided Self-Reflective Agent Framework for Virtual Cell Modeling
    Zhiyun Li, Rong Han, Xiao-Yu Wang, Guofeng Zhang, Wei-Xi Gao, Yusheng Su, Zihan Tian, Xiaohong Liu, Guangyu Wang · 2026 · Knowledge Discovery and Data Mining
  25. MBNL1 hijacks a structured single-stranded distal DNA element to sustain FLT3 expression in KMT2A-rearranged leukemias
    Meixia Che, Shaela Fields, Siqi Yi, Judith W. Hyle, Meng-Li Zhang, Bei-Si Xu, Yong Cheng, Peng Xu, Ya-Jun Jiang, Chun-Liang Li · 2026 · Science Advances
  26. Chromatin Landscape of Cancer Cell Lines Identifies Enhancer Subtypes
    M. Mattohti, E. Arslan, Ayush T. Raman, Christopher J. Terranova, Zhi-Yi Liu, Elias Orouji, Sanjana Srinivasan, V. Kochat, M. Tang, S. Amin et al. · 2026 · bioRxiv
  27. TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma
    D. Tsallos, N. Ikonen, Juho J Miettinen, M. Majumder, S. Eldfors, I. Vastrik, A. Parsons, M. Suvela, Katie Dunphy, P. Dowling et al. · 2026 · iScience
  28. Polygenic risk scores and plasma proteomics identify cancer-related proteins and trans-regulated protein networks
    Diptavo Dutta, Jingning Zhang, Xinyu Guo, Rosamund Quint, Mary R. Rooney, Mitchell J. Machiela, Kevin M Brown, Josef Coresh, Alexis J. Battle, Elizabeth A. Platz et al. · 2026 · Cell Genomics
  29. DSG2 Expression Marks a Stromal-Immune Organizational State in Head and Neck Squamous Cell Carcinoma
    Ömer Tarık Çiçek, M. O. Çakır, Begum Kurt, B. Yılmaz, G. Ashrafi, Mustafa Özdoğan · 2026 · Cancers
  30. Maintenance of nucleosome organization through replication and transcription counteracts aberrant coalescence of active chromatin
    R. Ciaran MacKenzie Frater, Rikke Rejnholdt Jensen, Joaquim Ollé-López, Valentin Flury, Jeroen van den Berg, Jonathan Humbert, Anton Lunow Bournonville, Nicolás Alcaraz, Simai Wang, Hannah J. Richter et al. · 2026 · Molecular Cell
  31. Nucleic acid modification therapy in cancer: Context, quantification, and network plasticity: Comment on "Decoding nucleic acid modification regulatory networks: A key to cancer intervention and treatment" by Sun et al.
    Hong-Ling Jia, Ke Li, Wenjing Xi, Q. Luo, Sen Hu · 2026 · Physics of Life Reviews
  32. Genome‐Wide Assessment of DNA Methylation Fidelity Identifies Representative Ovarian Cancer Cell Line Models
    Asia Jordan, Abby Caffrey, C. Stacy, R. Huang, T. Z. Tan, Aideen McCabe, Kellie Dean, Sudipto Das, A. Perry · 2026 · Journal of Cellular and Molecular Medicine
  33. MCKG-SL: Knowledge graph-based multi-feature cross-aggregation synthetic lethality prediction for KRAS gene
    Qian Liu, Ning Qiao, Hui Li, Qian Ma, Shikai Guo · 2026 · Artificial Intelligence in Medicine
  34. Oriented binding of transcription factors to nucleosomes remodels chromatin at human promoters.
    Tianyi Xiao, C. Crowe-McAuliffe, M. Ochmann, T. Warrier, Yepeng Du, Tianyun Hou, Si-Wei Zou, Yinan Chen, Fangjie Zhu, Dan Zhang et al. · 2026 · Molecules and Cells
  35. Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer
    Brett Schroeder, Jaehyun Choi, A. Schäffer, M. Nirula, Yingying Cao, Yang Zhang, A. Meinhardt, H. Kwon, H. Park, Sangin Lee et al. · 2026 · bioRxiv
  36. Genetic and epigenetic modifiers of metastasis: Context matters
    Danny R. Welch, Katy L. Swancutt, R. McKinnon Walsh, Gabrielle Fisette · 2026 · Quarterly Reviews of Biophysics
  37. E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling
    Charisa L Cottonham, Gloria E. Hernandez, Tommy K. Cheung, Christopher M. Rose, Rajini Srinivasan, R. Piskol, Xiaosai Yao, Christopher Siebel · 2026 · Cancer Research Communications
  38. RGS Family Remodeling in Breast Cancer: A Meta‐Analysis and Multi‐Omics Profiling of Prognostic Biomarkers
    Zohreh Mirzaei, Madiheh Mazaheri Moghaddam, Tahereh Barati, Amir Ebrahimi, M. S. Khaniani · 2026 · Cancer Medicine
  39. Molecular basis of the HPV E7-ZER1 axis reveals a ligandable vulnerability in HPV-positive cancers
    Xiaolu Wang, Chenhao Jiang, Yueling Zhao, Ruiyan Li, Yangyang Y. Zhou, Shiqi Yin, Jin Chen, Shuxin Yan, Shuhua Gu, Xinying Li et al. · 2026 · Cell Reports
  40. Complex assembly and activity states as multifaceted protein attributes explaining phenotypic variability
    George Rosenberger, Peng Xue, Isabell Bludau, Claudia Martelli, Evan G. Williams, Ben C. Collins, Andrea Califano, Yansheng Liu, Ruedi H. Aebersold · 2026 · Molecular Systems Biology
  41. CRISPR/Cas9-mediated UBC knockout impairs CD44 expression and reduces the metastatic potential of 23132/87 gastric cancer cells
    Libetti Debora, Anjum Ruhi, D. Pietro, Monittola Francesca, Crinelli Rita, Sparti Angelo, Magnani Mauro, Bianchi Marzia · 2026 · Scientific Reports
  42. A structure-based modeling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia
    Luke Jones, Oleksii S. Rukhlenko, Tânia Dias, Hiroaki Imoto, Ciardha Carmody, Kieran Wynne, Boris N. Kholodenko, Jonathan Bond · 2026 · iScience
  43. Synonymous mutations in essential genes infrequently produce fitness effects in human cell lines
    Yiyun Rao, Ivan Sokirniy, Edward P. O’Brien, Justin R. Pritchard · 2026 · Nucleic Acids Research
  44. A transcriptional biosensor reveals mechanisms of α-ketoglutarate signaling to chromatin
    Alex C. Sternisha, Haocheng Li, Kumar Gajendra, Yi Xiao, Xin Zhao, Jeffrey Isaac Traylor, Lei Guo, Ji Hyung Jun, Morgan Fleishman, Tracey Shipman et al. · 2026 · Science
  45. Models of high-grade serous carcinoma of tubo-ovarian origin
    Achuth Padmanabhan, Shailendra Kumar Dhar Dwivedi, Melissa A. Merritt, Priyanka Verma, Ronald J. Buckanovich, Jessica D. Lang, Hannah L. Dimmick, Kenneth P. Nephew, Ronny Drapkin, Lindsay W. Brubaker et al. · 2026 · Oncology Reviews
  46. Serum metabolomics profiling in head and neck squamous cell carcinoma: a multicentre diagnostic study
    He-Xin Ma, Xin-Ran Zhao, Zhihui Li, Zhen Zhang, Xin-Hua Pan, Mengxuan Du, Qing-Qing Wan, Chao-Jun Zhang, Xu Wang, Hongyu Zhao et al. · 2026 · EBioMedicine
  47. Multi-Omics and Clinical Data Analyses of Protein Arginine Methyltransferases in Pan-Cancer and Colorectal Cancer
    Jialing Xie, Qi-Hui Wu, Yuan-Yuan Xu, Jia-Xin Liu, Yan Wang, Xuan Wang, Xiao-Dan Fu, Yi-Min Li · 2026 · International Journal of Medical Sciences
  48. Autonomous computational prioritisation of colorectal cancer vulnerabilities via multi-scale AI swarms
    Christopher Baker, Tianyu Ren, Karen Rafferty, Hao Wang, Simon S. McDade · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  49. The PRECISE European initiative for cancer-vulnerability mapping and prediction
    F. Iorio, M. Garnett, P. Beltrao, Maximillian Billmann, Larissa Bless, Christoph Bock, M. Boutros, Alejandra Bruna, P. Carninci, G. Ciriello et al. · 2026 · Nature Genetics
  50. Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes
    Yoshitaka Sakamoto, Y. Ochi, Yasunori Kogure, S. Kato, A. Sato-Otsubo, M. Sugawa, Yosuke Tanaka, T. Tsujimura, Takashi Mikami, G. Nagae et al. · 2026 · bioRxiv
  51. Epithelial cancer cells co-opt the death ligand TRAIL to avert extrinsic apoptosis while acquiring killing capacity
    John Canty, Scot A. Marsters, David Lawrence, Serena Lee, Hartmut Koeppen, Avi Ashkenazi · 2026 · Cell Death and Differentiation
  52. Mapping the dialogue: Decoding alveolar stem–niche interactions
    Ahmad N. Nabhan, Anne Biton, Christine Everrett, Conrad Foo, Diana Wu, Joshua D. Webster, Alina A. Alam, Elisa Penna, Sandra Rost, Neha Rohatgi et al. · 2026 · Proceedings of the National Academy of Sciences
  53. SynTME: A tumor microenvironment-aware, pharmacology-inspired multi-stage framework for drug synergy prediction
    Song Gao, Peifu Han, Wei He, Jingyang Ge, Wen-Xu Li, Guo Chen, Zilin Liu, Shuang Wang, Tao Song, Na Kang · 2026 · Comput. Methods Programs Biomed.
  54. A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells
    Sami Nourreddine, Yesh Doctor, Amir Dailamy, Antoine Forget, Yi-Hung Lee, Rebecca Chinn, Hammza Khaliq, Benjamin J. Polacco, Monita Muralidharan, Emily Pan et al. · 2026 · Nature Biotechnology
  55. Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.
    Xuechun Wang, Yujing Qin, Loan D. Duong, Min-Zhi Liang, Adrian Chao, R. Parrotta, Yaoyin Li, P. Purohit, Yi-Hao Fang, Guo-Qiang Liu et al. · 2026 · Proceedings of the National Academy of Sciences of the United States of America
  56. Biochemistry at scale: Seeing both the forest and the trees
    Stefan A. Harry, Chirag Vasavda, Adam Wahida, Reilly Stevens, Harshabad Singh, I.David Goldman, Bruce Allan Chabner, Liron Bar‐Peled · 2026 · Trends in Biochemical Sciences
  57. Integrative analysis of gastric tissue transcriptomes and gastric cancer GWAS implicates candidate susceptibility genes
    Beiping Hu, Min Zhang, Yuhui Yu, Yongchao Liu, J H. -C. Wang, Aiping Zhang, Qian Li, Yun Gao, Zhe Li, Lijun Bian et al. · 2026 · The American Journal of Human Genetics
  58. Translational Control as a Driver of Tumor Plasticity, Metastasis, and Therapeutic Resistance in Triple-Negative Breast Cancer
    Tiffany J. Rios-Fuller, Harold I. Saavedra, Robert J. Schneider · 2026 · Disease and Therapeutics
  59. Deep learning reveals FLAD1-mediated mitochondrial metabolic reprogramming in hypoxic tumors
    Xiangyu Zhao, Tao Wu, Sanan Wu, Yuehua Chen, Yu Zhang, Jing Chen, Kaixuan Diao, Zaoke He, Jiawei Yan, Tianzhu Lu et al. · 2026 · Cell Reports
  60. A genome-wide functional analysis of conserved intronic regions reveals essential roles for speckle-associated retained introns.
    Shaghayegh Farhangmehr, Ulrich Braunschweig, Mingkun Wu, Syed Nabeel-Shah, Kevin R. Brown, Jacob L. Fine, Jason Moffat, B. Blencowe · 2026 · Cell Reports
  61. CRISPRing through time: How cutting-edge technology is revolutionizing life sciences and medicine
    Ishani Banik, Jean‐Philippe Coppé · 2026 · Molecular Therapy — Nucleic Acids
  62. Decoding Protein-Methylating METTLs in Humans: Structural, Functional, and Disease Insights over the Past Decade
    B. Baron · 2026 · International Journal of Molecular Sciences
  63. GSTT1 promotes stemness and FGFR inhibitor sensitivity in pancreatic cancer through regulation of CD133 (PROM1).
    Delgado Herrera Deborah de la Caridad, Alejandro Arroyo Roman, Riyan N. Campbell, E. Lasse-Opsahl, Carrie McCracken, L. Sadzewicz, Luke Tallon, E. Fertig, Christina M. Ferrer · 2026 · Cancer Letters
  64. GBFN: A gated bimodal fusion network leveraging foundation model embeddings for cancer drug sensitivity prediction
    Weijun Yang, Hu Zhou, X Li, Zhihang Zheng, Xinxing Li · 2026 · Computational Biology and Chemistry
  65. Repurposing simeprevir uncovers a druggable KPNB1-p65-BCL2 survival axis in cancer.
    Cong Li, Qiaohua Yan, Muhammad Muddasar Saeed, Yu-Bin Luo, Peidu Jiang, Qingxiang Sun · 2026 · Cell Chemical Biology
  66. FATP2-mediated Lipid Metabolism Enhances Chimeric Antigen Receptor T-Cell Therapy Resistance in B-cell Acute Lymphoblastic Leukemia
    Clarissa Garcia, K. Lyons, Julián Grandvallet Contreras, Tian Liu, Alexis J Donnelly, Amanda J. Novak, Amy Argabright, Colin C. Anderson, Abby L. Grier, Sabrina Smith et al. · 2026 · Leukemia
  67. DegradoMap: Multi-Modal Protein Representations Enable Pre-Synthesis Prediction of PROTAC Degradability
    Bryan Cheng, Jasper Zhang, Austin Jin · 2026 · ACM International Conference on Bioinformatics, Computational Biology and Biomedicine
  68. BASIS: An LLM-Empowered Benchmark and Agent System for Inferring Synthetic Lethality
    Yi Li, Siyu Tao, 冯贻苗, Jie Zheng · 2026 · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB)
  69. Autonomous mechanistic discovery of colorectal cancer vulnerabilities via multi-scale AI swarms
    Christopher Baker, Tianyu Ren, Karen Rafferty, Hui Wang, Simon S. McDade · 2026 · arXiv.org
  70. A Generalised Epigenetic Clock Reveals Therapeutic Vulnerabilities Linked to Ageing in Cancer Cells
    Irene Fernández-Rebollo, A. Digilio, Athanasios Oikonomou, L. Trastulla, M. Esteller, F. Iorio · 2026 · bioRxiv
  71. Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles
    Yu-Nan Man, Mao-Lin He · 2026 · Cancer Biology & Therapy
  72. A living biobank of sarcoma patient‐derived cell cultures reveals multi‐omic and functional insights that capture disease heterogeneity
    Stefanie Gijsels, Suzanne Fischer, David Creytens, Sándor Dedeyne, Felix De Vuyst, Cláudio Pinheiro, Fleur Cordier, Sarah-Lee Bekaert, Nadine Van Roy, Kaat Durinck et al. · 2026 · Clinical and Translational Medicine
  73. Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stress
    Giacomo Milletti, Giulia Cadeddu, Alba Adelantado-Rubio, Caterina Ferraina, Kristina Keuper, Sebastian Howen Nesgaard Munk, Cristiano De Stefanis, Denise Quacquarini, Sabrina Rossi, Angela Mastronuzzi et al. · 2026 · Nucleic Acids Research
  74. Integrative Transcriptomic and Proteomic Profiling Identifies S100P as a Potential Functional Biomarker for Sessile Serrated Lesions
    Jen-Hao Yeh, Chia-Chi Chen, Chih-I Chen, Chao-Ming Hung, Chu-Kuang Chou, Tsung-Hsien Chen, Jaw-Yuan Wang, S. Moi, Yu-Peng Liu · 2026 · Digestive Diseases and Sciences
  75. NCES: A Cell-Specific Network-Augmented Essentiality Framework for Cancer Therapeutic Target Discovery
    Jinmyung Jung, Sunyong Yoo · 2026 · Computational and Structural Biotechnology Journal
  76. Pillbox: A Leakage-Aware Foundation-Model Predictor and Lineage-Ceiling Diagnostic for Cancer Drug Response
    Justin Hill, Eric Jiao, Shwetank Singh, Arhant Ghanta, Declan Anders, Joo ho Jeong, Hong Joo Ryoo · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1
    Matthew Tcheng, V. Voisin, G. Thomas, A. A. Piric, M. Gronda, R. Hurren, Da-Kai Ling, Yong-Ran Yan, Lan-Xing Zhang, Yue Feng et al. · 2026 · Journal of Clinical Investigation
  78. FORGE-CRISPR: Reusable Modules for Focused CRISPR Library Construction
    Ji-Ann Lee, D. Conklin, M. Palazzolo, Jay M. Lee, S. Dubinett · 2026 · bioRxiv
  79. Comprehensive multi-omics and single-cell analysis reveals a ferroptosis signature associated with tumor microenvironment remodeling and therapeutic decision-making across pan-cancer
    Yanan Qu, Qiu-Xia Wei, Chao-Ling Wu, Nigmat Rahim, Jiahao Luo, Jinhai Deng, Wenping Hu, Jing Liu, Li-Qun Wang, Xiaoyan Lin et al. · 2026 · International Journal of Surgery
  80. Predicting gene essentiality and drug response from preclinical perturbation screens with layered ensemble of autoencoders and predictors
    B. Bodinier, G. Dissez, Lucile Ter-Minassian, Linus Bleistein, Roberta Codato, John Klein, Eric Y. Durand, Antonin Dauvin · 2026 · Scientific Reports
  81. CRISPR application in hematological disorders: from bench to bedside
    Francesco Ladisa, Eugenio Morelli, D. Soncini, Matteo Garibotto, Nikhil C. Munshi, M. Fulciniti, M. Cea · 2026 · Blood Advances
  82. Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers
    Jared D. W. Price, Frederick S Vizeacoumar, Omar Abuhussein, Vincent Maranda, Yue Zhang, Hironori Adachi, Kathryn Nguyen, Liliia Kyrylenko, Aline Rangel Pozzo, He Dong et al. · 2026 · Signal Transduction and Targeted Therapy
  83. Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in KRAS-mutant non–small cell lung cancer
    Nicole Novaresi, Poorva Ghosh, Shayna Thomas-Jardin, Hui Deng, Xue-Jun Fan, Z. Ku, Wei Xiong, Xiao-Rong Zhou, Jingfei Zhu, Huiyu Li et al. · 2026 · Science Advances
  84. Targeting the transcriptional coactivator p300/CBP in cancer: Mechanistic insights and translational implications for osteosarcoma
    Tatsuya Masuda, Yasutoshi Tatsumi, Takayoshi Watanabe, Yasuhiko Kamikubo · 2026 · Pharmacological Research
  85. Structure-Aware Prediction of PROTAC-Mediated Protein Degradability via Graph Neural Networks
    Bryan Cheng, Austin Jin · 2026 · arXiv.org
  86. Integrating Genome-Scale Metabolic Modeling with Machine Learning Improves Gene Essentiality Prediction in Triple-Negative Breast Cancer
    Bo Kyung Kim, Changdai Gu, Mohamed El-Agamy Farh, Jae Yong Ryu · 2026 · International Journal of Molecular Sciences
  87. Unconventional activation of the proto-oncogene FGFR1 by extracellular phosphate via H2O2-mediated kinase oxidation.
    Michał Kostas, E. Munthe, E. Haugsten, D. Mateus, V. Sørensen, Jon K. Laerdahl, P. Szybowska, A. Wiedlocha, L. A. Lecaudey, S. Nakken et al. · 2026 · Cell Reports
  88. Pan-cancer 8q24 amplification predicts primary immunotherapy resistance and therapeutic vulnerabilities
    Changyuan Chen, ShuYe Liu, Jingxiu Feng, Zhihong Luo, Yun Bi, Q C Huang, Yue Zhang, H Yu, J Wu, H Yu et al. · 2026 · iScience
  89. Harnessing computational intelligence for synthetic lethality: A roadmap from network biology to interpretable deep learning in precision oncology.
    Yumi Noh, M. Farh, Jae Yong Ryu, W. Jang · 2026 · New Biotechnology
  90. Small Molecule Liver X Receptor Modulator GAC0001E5 Targets Mechanisms of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer Cells
    Shinjini Basu, Asitha Premaratne, Scott Widmann, Esther A. Olaleye, Chin-Yo Lin · 2026 · Biomolecules
  91. Characterizing selection signatures in coding and noncoding regions of 14,886 cancer genomes
    Mengyue Zheng, Xiwei Sun, Junren Hou, Minmin Guo, Xinran Liu, Wen Yang, Jian Yang · 2026 · Journal of genetics and genomics/Journal of Genetics and Genomics
  92. CRISPR approaches: Modeling tumor-stroma interactions and their role in cancer progression
    Brizal Raninga, Praveen Suresh Gupta · 2026 · Gene Reports
  93. Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework
    M. El-Tanani, A. Wali, S. A. Rabbani, Yahia El-Tanani, I. Rangraze, F. Muhana · 2026 · Pharmaceuticals
  94. Deep Learning for Anticancer Drug Discovery Targeting Non-Apoptotic Regulated Cell Death Mechanisms
    Mengwan Jiang, Jinlun Mu, Shuoye Yang, Peng Li · 2026 · Pharmaceuticals
  95. H3K18la-PSMG1 Axis in Bladder Cancer Progression: Curcumin as a Therapeutic Candidate
    Zhe Yu, Jinge Zhang, Zi-Huan Wang, Shu Wei, Chen Chen, Yuan Huang, Qing-Feng Fan, Fan Deng, Haiyong Chen, Zhangfeng Zhong et al. · 2026 · International Journal on Biological Sciences
  96. An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates
    Rui Zuo, Mi Wang, Yun-Ting Wang, Jenny Z. Hu, Alexandra K. Moura, Dan Wang, Pin-Lan Li, Ming-Fu Wu, Tahir Hussain, Weiran Gao et al. · 2026 · bioRxiv
  97. Generating Labeled Low-Heterogeneity Transcriptomes Using CRISPRa and CRISPRi Can Improve Phenotype Prediction by Deep Learning.
    I. Velegzhaninov, D. Kazakov, E. Rasova, Sofiia Zaplavnaia, Dmitry Klokov · 2026 · ACS Synthetic Biology
  98. Spatial Regulation of CAR Signaling Enables Logic-Gated Activity
    T. Nichakawade, B. Mog, A. Pearlman, Taha S. Ahmedna, Nikita Marcou, Ricardo Mora-Cartin, E. Watson, B. Lee, Sarah R. DiNapoli, N. Papadopoulos et al. · 2026 · bioRxiv
  99. Initial leukemic epigenomic state determines hypomethylating agent response
    Aparna Gopal, Derek Tam, F. Mey, Diana Lin, Christina May, Ji-Hong Jiang, Josh Bridgers, B. Caswell, K. O’Neill, F. Vizeacoumar et al. · 2026 · Nature Communications
  100. ACSL4-driven ferroptosis susceptibility as a targetable vulnerability in monocytic acute myeloid leukemia
    F. De Marchi, M. Gottardi · 2026 · Frontiers in Oncology